Sanofi snaps up OTC rights to Tamiflu in US

23 July 2019 - Deborah Wilkes

Premium

Sanofi has gained exclusive OTC rights to Roche's Tamiflu (oseltamivir) for prevention and treatment of flu in the US.

Click tags below for more information on topics:

Sanofi Consumer Healthcare FDA

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: